Company Registration No. 09557999 (England and Wales)
THE STAGE SHOREDITCH (OFFICE SOUTH) GP LIMITED
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
THE STAGE SHOREDITCH (OFFICE SOUTH) GP LIMITED
COMPANY INFORMATION
Directors
Mr J S Goldstein
Mr J Lang
Mr J N D Stelzer
(Appointed 29 April 2025)
Company number
09557999
Registered office
72 Welbeck Street
London
W1G 0AY
United Kingdom
Auditor
Ernst & Young LLP
Liberation House
Castle Street
St Helier
Jersey
JE1 1EY
Channel Islands
THE STAGE SHOREDITCH (OFFICE SOUTH) GP LIMITED
CONTENTS
Page
Directors' report
1 - 2
Directors' responsibilities statement
3
Independent auditor's report
4 - 6
Statement of comprehensive income
7
Statement of financial position
8
Statement of changes in equity
9
Notes to the financial statements
10 - 16
THE STAGE SHOREDITCH (OFFICE SOUTH) GP LIMITED
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 DECEMBER 2025
- 1 -

The directors present their report of The Stage Shoreditch (Office South) GP Limited (the ''Company'') for the year ended 31 December 2025.

Principal activities

The principal activity of the Company is to act as a general partner of The Stage Shoreditch (Office South) Limited Partnership ('LP').

Results and dividends

The profit for the period, after taxation, amounted to £20,445 (2024: £852). During the year, the directors did not recommend any dividend payment (2024: £nil).

Directors

The directors who held office during the year and up to the date of approval of the financial statements were as follows:

Mr J S Goldstein
Mr S S Conway
(Resigned 31 March 2025)
Mr J Lang
Mr G Conway
(Resigned 18 September 2025)
Mr J Cole
(Resigned 29 April 2025)
Mr J N D Stelzer
(Appointed 29 April 2025)
Qualifying third party indemnity provisions

The Company has granted an indemnity to its directors against liability in respect of proceedings brought by third parties, subject to the conditions set out in section 234 of the Companies Act 2006. Such qualifying third party indemnity provision remains in force as at the date of approving the directors' report.

Future developments

The directors anticipate that the activity of the Company will continue for the foreseeable future.

Going concern

The financial statements have been prepared on a going concern basis, which assumes the Company will be able to meet its liabilities as and when they fall due from the date of approval of the financial statements through to 30 September 2027 (the ‘going concern period’). At 31 December 2025, the Company has net current liabilities of £90,631 (2024: £111,076) and net liabilities of £90,621 (2024: £111,066).

The directors have assessed the going concern period under assessment to be the period from the date of approval of the financial statements through the going concern period.

The directors of the Company have prepared a robust forecast of the anticipated operational outgoings of the Company over its going concern period. In preparing the cash flow forecast for the Company as part of the group of companies (“Commercial Group”) party to the Mizuho facility over the going concern period, the directors have considered all known operational expenses.

The directors have received written confirmation from the parent of the Commercial Group, The Stage Shoreditch LLP (“LLP”), that it does not intend to call upon the Company to repay any intra-group debts unless the Company has the cash available to settle the debts.

Furthermore, the cash flow forecast demonstrates that the Company will be able to meet the liabilities as they fall due during the going concern period.

The directors therefore consider it appropriate to prepare the Company’s accounts on a going concern basis for the going concern review period to 30 September 2027.

Auditor

Ernst & Young LLP were re-appointed as auditor to the Company and in accordance with section 485 of the Companies Act 2006, a resolution proposing that they be re-appointed will be put at a General Meeting.

THE STAGE SHOREDITCH (OFFICE SOUTH) GP LIMITED
DIRECTORS' REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 2 -
Strategic report and director's report disclosures

The Company has taken the exemption under Section 414B of the Companies Act 2006 from the requirement to prepare a Strategic Report for the financial period. In preparing this report, the directors have taken the advantage of the exemptions under the small companies regime provided by section 415A of the Companies Act 2006 from certain D irectors' R eport disclosures.

Statement of disclosure to auditor

So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the Company’s auditor is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the Company’s auditor is aware of that information.

Subsequent events

Details of any subsequent events are set out in note 1 4.

This report has been approved by the board on 24 June 2026 and has been prepared in accordance with the small companies regime of the Companies Act 2006.

On behalf of the board
Mr J S Goldstein
Director
30 June 2026
THE STAGE SHOREDITCH (OFFICE SOUTH) GP LIMITED
DIRECTORS' RESPONSIBILITIES STATEMENT
FOR THE YEAR ENDED 31 DECEMBER 2025
- 3 -

The directors are responsible for preparing the D irectors' Report and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law) including Financial Reporting Standard 102, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'. Under C ompany law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the C ompany and of the profit or loss of the C ompany for that period. In preparing these financial statements, the directors are required to:

- select suitable accounting policies and then apply them consistently;

- make judgements and accounting estimates that are reasonable and prudent;

- state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements; and

- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the C ompany will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the C ompany’s transactions and disclose with reasonable accuracy at any time the financial position of the C ompany and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the C ompany and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

THE STAGE SHOREDITCH (OFFICE SOUTH) GP LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF THE STAGE SHOREDITCH (OFFICE SOUTH) GP LIMITED
- 4 -
Opinion

We have audited the financial statements of The Stage Shoreditch (Office South) GP Limited (the ‘Company’) for the year ended 31 December 2025 which comprise the Statement of Comprehensive Income, the Statement of Financial Position, the Statement of Changes in Equity and the related notes 1 to 14, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards including FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

- give a true and fair view of the state of the Company's affairs as at 31 December 2025 and of its profit for the year then ended;

- have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and

- have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor’s responsibilities for the audit of the financial statements section of our report. We are independent of the Company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard and we have fulfilled our other ethical responsibilities in accordance with these requirements.

We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the Company's ability to continue as a going concern for a period of at least 12 months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report. However, because not all future events or conditions can be predicted, this statement is not a guarantee as to the Company’s ability to continue as a going concern.

Other information

The other information comprises the information included in the annual report, other than the financial statements and our auditor’s report thereon. The directors are responsible for the other information contained within the annual report.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in this report, we do not express any form of assurance conclusion thereon.

Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of the other information, we are required to report that fact.

We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of our audit:

- the information given in the directors' report for the financial year for which the financial statements are prepared is consistent with the financial statements; and

- the directors' report has been prepared in accordance with applicable legal requirements.

THE STAGE SHOREDITCH (OFFICE SOUTH) GP LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF THE STAGE SHOREDITCH (OFFICE SOUTH) GP LIMITED
- 5 -
Matters on which we are required to report by exception

In the light of the knowledge and understanding of the C ompany and its environment obtained in the course of the audit, we have not identifie d material misstatements in the directors' r eport.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:

- adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or

- the financial statements are not in agreement with the accounting records and returns; or

- certain disclosures of directors' remuneration specified by law are not made; or

- we have not received all the information and explanations we require for our audit; or

- the directors were not entitled to prepare the financial statements in accordance with the small companies regime and take advantage of the small companies' exemption in preparing the directors' report and take advantage of the small companies exemption from the requirement to prepare a strategic report.

Responsibilities of directors

As explained more fully in the directors’ responsibilities statement set out on page 3, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the Company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the Company or to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.
Explanation as to what extent the audit was considered capable of detecting irregularities, including fraud

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect irregularities, including fraud. The risk of not detecting a material misstatement due to fraud is higher than the risk of not detecting one resulting from error, as fraud may involve deliberate concealment by, for example, forgery or intentional misrepresentations, or through collusion. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below. However, the primary responsibility for the prevention and detection of fraud rests with both those charged with governance of the entity and management.

Our approach was as follows:

- We obtained an understanding of the legal and regulatory frameworks that are applicable to the Company and determined that the most significant are the Companies Act 2006, and those relating to its reporting framework being United Kingdom Generally Accepted Accounting Practice.

- We understood how the Company is complying with those frameworks by making enquiries of management and those responsible for legal and compliance procedures. We corroborated our enquiries through our review of minutes of board meetings of the Company as well as validating how policies and procedures in these areas are communicated and monitored. We also read any correspondence with relevant authorities.

THE STAGE SHOREDITCH (OFFICE SOUTH) GP LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF THE STAGE SHOREDITCH (OFFICE SOUTH) GP LIMITED
- 6 -

- We assessed the susceptibility of the Company’s financial statements to material misstatement, including how fraud might occur by making enquiries of management and those charged with governance. Where this risk was considered to be higher, we performed audit procedures in response to the identified fraud risks. These procedures included testing of specific accounting journal entries. We also considered management’s incentives around improving the performance of the Company, the opportunities available to execute any such actions through management override as well as the controls that the Company has established to address any such risks identified, including to prevent, deter and detect fraud and the monitoring of such controls by management.

- Based on this understanding we designed our audit procedures to identify non-compliance with such laws and regulations. Our procedures involved supplementing our enquiries of management and those charged with governance with review of meeting minutes.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council’s website at https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor’s report.

Use of our report

This report is made solely to the Company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the Company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Company and the Company's members, as a body, for our audit work, for this report, or for the opinions we have formed.

Christopher James Matthews, FCA (Senior statutory auditor)
For and on behalf of Ernst & Young LLP
Statutory Auditor
Jersey
Channel Islands
30 June 2026
THE STAGE SHOREDITCH (OFFICE SOUTH) GP LIMITED
STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 DECEMBER 2025
- 7 -
2025
2024
Notes
£
£
Administrative expenses
20,445
852
Profit before taxation
3
20,445
852
Tax on profit on ordinary activities
6
-
0
-
0
Total profit for the year
20,445
852
Other comprehensive income
-
-
Total comprehensive income for the year
20,445
852

The notes on pages 10 - 16 form part of these financial statements.

The statement of comprehensive income has been prepared on the basis that all amounts relate to continuing operations.

THE STAGE SHOREDITCH (OFFICE SOUTH) GP LIMITED
STATEMENT OF FINANCIAL POSITION
AS AT
31 DECEMBER 2025
31 December 2025
- 8 -
2025
2024
Notes
£
£
£
£
Fixed assets
Investments
7
10
10
Current assets
Debtors
8
399,285
424,011
Cash at bank and in hand
79,610
452
478,895
424,463
Creditors: amounts falling due within one year
9
(569,526)
(535,539)
Net current liabilities
(90,631)
(111,076)
Total assets less current liabilities
(90,621)
(111,066)
Net liabilities
(90,621)
(111,066)
Capital and reserves
Called up share capital
10
100
100
Profit and loss reserves
(90,721)
(111,166)
Total equity
(90,621)
(111,066)

The notes on pages 10 - 1 6 form part of these financial statements.

These financial statements have been prepared in accordance with section 1A of FRS 102 applicable for the small companies regime.

The financial statements on pages 7 - 16 were approved by the board of directors and authorised for issue on 24 June 2026 and are signed on its behalf by:
Mr J S Goldstein
Director
Company Registration No. 09557999
THE STAGE SHOREDITCH (OFFICE SOUTH) GP LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2025
- 9 -
Share capital
Profit and loss reserves
Total
£
£
£
Balance at 1 January 2024
100
(112,018)
(111,918)
Year ended 31 December 2024:
Total comprehensive income for the year
-
852
852
Balance at 31 December 2024
100
(111,166)
(111,066)
Year ended 31 December 2025:
Total comprehensive income for the year
-
20,445
20,445
Balance at 31 December 2025
100
(90,721)
(90,621)
The notes on pages 10 - 16 form part of these financial statements.
THE STAGE SHOREDITCH (OFFICE SOUTH) GP LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
- 10 -
1
Accounting policies
Company information

The Stage Shoreditch (Office South) GP Limited is a private company limited by shares incorporated in England and Wales. The registered office is 72 Welbeck Street, London, W1G 0AY. The Company number is 09557999. The Company was incorporated on 23 April 2015.

1.1
Statement of compliance

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

1.2

Basis of preparation

The financial statements are prepared in sterling, which is the functional and presentation currency of the Company. Monetary amounts in these financial statements are rounded to the nearest £. The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

The Company has taken the exemption under section 1A.7 of FRS 102 from the requirement to prepare a statement of cash flows and related disclosures for the financial period.

1.3
Going concern

The financial statements have been prepared on a going concern basis, which assumes the Company will be able to meet its liabilities as and when they fall due from the date of approval of the financial statements through to 30 September 2027 (the ‘going concern period’). At 31 December 2025, the Company has net current liabilities of £90,631 (2024: £111,076) and net liabilities of £90,621 (2024: £111,066). true

The directors have assessed the going concern period under assessment to be the period from the date of approval of the financial statements through the going concern period.

The directors of the Company have prepared a robust forecast of the anticipated operational outgoings of the Company over its going concern period. In preparing the cash flow forecast for the Company as part of the group of companies (“Commercial Group”) party to the Mizuho facility over the going concern period, the directors have considered all known operational expenses.

The directors have received written confirmation from the parent of the Commercial Group, The Stage Shoreditch LLP (“LLP”), that it does not intend to call upon the Company to repay any intra-group debts unless the Company has the cash available to settle the debts.

Furthermore, the cash flow forecast demonstrates that the Company will be able to meet the liabilities as they fall due during the going concern period.

The directors therefore consider it appropriate to prepare the Company’s accounts on a going concern basis for the going concern review period to 30 September 2027.

1.4
Fixed asset investments

Equity investments are measured at fair value through profit or loss, except for those equity investments that are not publicly traded and whose fair value cannot otherwise be measured reliably, which are recognised at cost less impairment until a reliable measure of fair value becomes available.

In the financial statements, investments in subsidiaries are initially measured at cost and subsequently measured at cost less any accumulated impairment losses.

THE STAGE SHOREDITCH (OFFICE SOUTH) GP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 11 -

A subsidiary is an entity controlled by the Company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities. The results of the Company are included in the consolidated financial statements of The Stage Shoreditch LLP, an entity incorporated in England and Wales. The financial statements of The Stage Shoreditch LLP are prepared in accordance with FRS102 and can be obtained from 72 Welbeck Street, London W1G 0AY. Thus, the Company has taken the exemption under section 9.3 of FRS 102 from the requirement to consolidate results of its subsidiary for the financial period.

1.5
Cash and cash equivalents

Cash and cash equivalents comprise of cash in hand and in bank and are subject to insignificant risk of changes in fair value.

1.6
Financial instruments

The Company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the Company's statement of financial position when the Company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Impairment of financial assets

Financial assets, other than those held at fair value through profit or loss, are assessed for indicators of impairment at each reporting end date.

Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset and it is certain that the carrying amount will not be recovered in full. If an asset is impaired, the impairment loss is the difference between the carrying amount and recoverable amount. The impairment loss is recognised in profit or loss.

If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.

Derecognition of financial assets

Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the Company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

THE STAGE SHOREDITCH (OFFICE SOUTH) GP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 12 -
Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Derecognition of financial liabilities

Financial liabilities are derecognised when the Company’s contractual obligations expire or are discharged or cancelled.

1.7
Equity instruments

Equity instruments issued by the Company are recorded at the proceeds received, net of transaction costs.

1.8
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the income statement because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The Company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred taxation is provided in full in respect of taxation deferred by timing differences between the treatment of certain items for taxation and accounting purposes. Unrelieved tax losses and other deferred tax assets are recognised only to the extent it is more likely than not that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

THE STAGE SHOREDITCH (OFFICE SOUTH) GP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 13 -
2
Judgements and key sources of estimation uncertainty

In the application of the Company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

Critical judgements

The following judgements (apart from those involving estimates) have had the most significant effect on amounts recognised in the financial statements.

Impairment of debtors

The Company makes a judgement of the recoverable value of trade and other debtors. When assessing impairment of trade and other debtors, management consider factors including the ageing profile and historical experience. The debtor balance at the reporting date includes a provision for impairment, see note 8 for carrying amount of debtors.

Key sources of estimation uncertainty

The estimates and assumptions which have a significant risk of causing a material adjustment to the carrying amount of assets and liabilities are as follows.

Estimates
Taxation

The Company establishes provisions based on reasonable estimates based on various factors, such as experience with previous tax audits and differing interpretations of tax regulations by the taxable entity and the responsible tax authority. Management estimation is required to determine the amount of deferred tax assets that can be recognised based upon likely timing and level of future taxable profits together with an assessment of the effect of future tax planning strategies.

Accrued expenses

The Company recognises estimates in relation to accrued expenses recorded at the year end based on past experience of similar outgoings incurred or their knowledge of the expected outgoings to be incurred depending on the nature of goods or services rendered that are yet to be billed.

3
Profit before taxation
2025
2024
Profit before tax for the year is stated after charging:
£
£
Audit fees
7,970
4,614
Reversal of impairment of amount due from group undertaking
(37,550)
(18,042)

No non-audit services were provided during the year (2024: £nil).

4
Employees

The number of persons employed by the Company during the year was nil (2024: nil).

THE STAGE SHOREDITCH (OFFICE SOUTH) GP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 14 -
5
Directors' remuneration

All directors of the Company received no remuneration during the current year (2024: £nil) from the Company or any entities within the Group. The directors believe that their qualifying services provided to the Company are incidental to the qualifying services provided to the members of The Stage Shoreditch LLP.

6
Taxation

The actual charge for the year can be reconciled to the expected charge for the year based on the profit or loss and the standard rate of tax as follows:

2025
2024
£
£
Profit before taxation
20,445
852
Expected tax charge based on the standard rate of corporation tax in the UK of 25.00% (2024: 25.00%)
5,111
213
Tax effect of expenses that are not deductible in determining taxable profit
50
-
0
Tax effect of income not taxable in determining taxable profit
(9,387)
(4,510)
Unutilised tax losses carried forward
2,534
4,297
Thin cap/Anti-hybrid disallowance
1,692
-
0
Taxation charge for the year
-
-

The Company has cumulative taxable losses arising in the UK of £53,796 (2024: £46,554) that are available indefinitely for offset against future taxable profits.

Deferred tax assets have not been recognised in respect of these losses as it is unlikely they will be recovered against the reversal of deferred tax liabilities or other future taxable profits for the foreseeable future.

7
Fixed asset investments
2025
2024
£
£
Investments
10
10

On 8 May 2015, the Company wholly invested in the ordinary share capital of The Stage Shoreditch (Office South) Nominee Limited, registered in England and Wales. The cost and carrying amount of the investment is £10. The Company has full control over The Stage Shoreditch (Office South) Nominee Limited and consider it as a subsidiary.

The Company also has an investment in The Stage Shoreditch (Office South) Limited Partnership, which represents a 0.1% holding in the LP, which was established under a Limited Partnership Deed dated 22 May 2015. The cost and carrying amount of the investment is £0.01. The Limited Partnership is registered in England & Wales in accordance with The Limited Partnerships Act 1907. The Company does not control The Stage Shoreditch (Office South) Limited Partnership.

THE STAGE SHOREDITCH (OFFICE SOUTH) GP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
7
Fixed asset investments
(Continued)
- 15 -
Movements in fixed asset investments
Shares in group undertakings
£
Cost
At 1 January 2025 & 31 December 2025
10
Carrying amount
At 31 December 2025
10
At 31 December 2024
10
8
Debtors
2025
2024
Amounts falling due within one year:
£
£
Amounts owed by group undertakings
396,954
381,403
Other debtors
2,331
42,608
399,285
424,011

Amounts due from group undertakings are unsecured, interest free and payable on demand without restrictions. Amounts due from group undertakings are stated after provisions for impairment of £35,525 (2024: £73,075) after reversal of £37,550 in the current year.

Amounts falling within one year based on the contractual term of payable on demand, however these amounts are not expected to be realised within next one year but intended to be settled within the foreseeable period.

9
Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
14,075
-
0
Amounts owed to group undertakings
541,616
520,225
Accruals and deferred income
13,835
15,314
569,526
535,539

Amounts due to group undertakings are unsecured, interest free and payable on demand without restrictions.

Included in amounts due to group undertakings is an unsecured, interest free loan from The Stage Shoreditch LLP, the parent undertaking of the Group, of £336,954 (2024: £336,954) which is payable on demand without restrictions.

THE STAGE SHOREDITCH (OFFICE SOUTH) GP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 16 -
10
Share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Authorised, Issued and fully paid
100 ordinary shares of £1 each
100
100
100
100

The ordinary shares entitles the holder to participate in dividend distribution rights on the winding up of the Company. The Company has profit or loss reserves which comprises of the total comprehensive income or loss since inception.

11
Commitments

As at 31 December 2025, the Company has provided a guarantee in respect of a commercial loan of £124.3m (2024: £118.6m) held with Mizuho Bank Limited via a fixed and floating charge on its assets and shares. The Company does not have any other financial commitments, guarantees and contingencies aside from the disclosed commitments.

12
Related party transactions

Amounts due to the parent undertaking of the Group, The Stage Shoreditch LLP, are noted within note 9.

At 31 December 2025, the amounts due from other members of the Group was £396,954 (2024: £381,403) and the amounts due to other members of the Group was £204,662 (2024: £183,271).

The Company has taken advantage of the exemption afforded by FRS 102.33.1A not to disclose transactions between wholly owned members of the Group.

13
Parent undertaking

The Company's immediate parent undertaking is The Stage Shoreditch (Office South) Unit Trust, an entity incorporated in Jersey. The smallest group in which the results of the Company are consolidated is that prepared by The Stage Shoreditch LLP. Copies of the consolidated financial statements of The Stage Shoreditch LLP are publicly available from 72 Welbeck Street, London, W1G 0AY.

The largest group in which the results of the Company are consolidated is that prepared by Eldridge Industries LLC, of 600 Steamboat Road, Greenwich, CT 06830. The financial statements of this entity are not publicly available.

14
Subsequent events

There are no subsequent events to report.

2025-12-31 2025-01-01 false false false CCH Software CCH Accounts Production 2026.100 Mr J S Goldstein Mr S S Conway Mr J Lang Mr G Conway Mr J Cole Mr J N D Stelzer 0 09557999 2025-01-01 2025-12-31 09557999 bus:Director1 2025-01-01 2025-12-31 09557999 bus:Director3 2025-01-01 2025-12-31 09557999 bus:Director6 2025-01-01 2025-12-31 09557999 bus:Director2 2025-01-01 2025-12-31 09557999 bus:Director4 2025-01-01 2025-12-31 09557999 bus:Director5 2025-01-01 2025-12-31 09557999 bus:RegisteredOffice 2025-01-01 2025-12-31 09557999 2025-12-31 09557999 2024-01-01 2024-12-31 09557999 2024-12-31 09557999 core:CurrentFinancialInstruments core:WithinOneYear 2025-12-31 09557999 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 09557999 core:ShareCapital 2025-12-31 09557999 core:ShareCapital 2024-12-31 09557999 core:RetainedEarningsAccumulatedLosses 2025-12-31 09557999 core:RetainedEarningsAccumulatedLosses 2024-12-31 09557999 core:ShareCapital 2023-12-31 09557999 core:RetainedEarningsAccumulatedLosses 2023-12-31 09557999 2023-12-31 09557999 core:ShareCapitalOrdinaryShareClass1 2025-12-31 09557999 core:ShareCapitalOrdinaryShareClass1 2024-12-31 09557999 core:RetainedEarningsAccumulatedLosses 2024-01-01 2024-12-31 09557999 core:RetainedEarningsAccumulatedLosses 2025-01-01 2025-12-31 09557999 core:UKTax 2025-01-01 2025-12-31 09557999 core:UKTax 2024-01-01 2024-12-31 09557999 1 2025-01-01 2025-12-31 09557999 1 2024-01-01 2024-12-31 09557999 2 2025-01-01 2025-12-31 09557999 2 2024-01-01 2024-12-31 09557999 core:Non-currentFinancialInstruments 2025-12-31 09557999 core:Non-currentFinancialInstruments 2024-12-31 09557999 core:CurrentFinancialInstruments 2025-12-31 09557999 core:CurrentFinancialInstruments 2024-12-31 09557999 bus:OrdinaryShareClass1 2025-01-01 2025-12-31 09557999 bus:OrdinaryShareClass1 2025-12-31 09557999 bus:OrdinaryShareClass1 2024-12-31 09557999 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 09557999 bus:FRS102 2025-01-01 2025-12-31 09557999 bus:Audited 2025-01-01 2025-12-31 09557999 bus:FullAccounts 2025-01-01 2025-12-31 xbrli:pure xbrli:shares iso4217:GBP